NCT03577444

Brief Summary

The purpose of this study is to assess the association of genetic polymorphism such as the Brain-derived Neurotrophic factor (BDNF), in neurogenic dysphagia in those with brain lesion.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
220

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2018

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 8, 2018

Completed
27 days until next milestone

First Posted

Study publicly available on registry

July 5, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

August 4, 2018

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2019

Completed
8 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 7, 2019

Completed
Last Updated

August 8, 2019

Status Verified

July 1, 2019

Enrollment Period

12 months

First QC Date

June 8, 2018

Last Update Submit

August 6, 2019

Conditions

Keywords

gene polymorphismstrokedysphagiapoststroke recovery

Outcome Measures

Primary Outcomes (1)

  • Change in Functional Oral Intake Scale(FOIS)

    Functional oral intake scale(FOIS) is categorical scale range from 1 indicating severe dysphagia and 7 indicating safe oral feeding. Higher change in FOIS indicates improvement of patient's swallowing function.

    initial 4 weeks,3months after onset

Secondary Outcomes (11)

  • Change in Berg Balance Scale(BBS)

    initial 4 weeks, 3 months after onset

  • Change in Medical Research Council(MRC) grade Disability level

    initial 4 weeks, 3 months after onset

  • Change in K-MBI(Korean Modified Barthel Index)

    initial 4 weeks, 3 months after onset

  • Change in FAC(Functional Ambulatory Category)

    initial 4 weeks, 3 months after onset

  • Change in Fugyl Meyer score from baseline

    initial 4 weeks, 3 months after onset

  • +6 more secondary outcomes

Study Arms (1)

Dysphagia patients

Patients who had been diagnosed with neurogenic dysphagia related to either stroke or traumatic brain injury at two university affiliated hospitals

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients who had were diagnosed with first dysphagia and referred to Department of Rehabilitation( in Bucheon St. Mary's Hospital and National Traffic Injury Rehabilitation Hospital) with medical records up to 6 months after onset of brain lesion

You may qualify if:

  • Patients who had been diagnosed with first ever brain lesions ( stroke and traumatic brain lessons) and referred to Department of Rehabilitation( in Bucheon St. Mary's Hospital and National Traffic Injury Rehabilitation Hospital)
  • Patients who were hospitalized for 30 days and were followed up at 3 months after the onset of brain lesions
  • Patients who agree to participate in the study or if the guardian or legal representative agrees only if the patient has difficulties in consenting or consenting to participate directly in the language disability.
  • In the case of a suspected feeding swallowing disorder in the patient, the patient should be confirmed by VFSS(Videofluoroscopic Swallwing Study) or FEES(Fiberoptic Endoscopic Evaluation of Swallowing)

You may not qualify if:

  • Patients who do not meet the above criteria
  • Patients with difficulty in collecting blood for genetic testing
  • Patients who were not able to followed-up for 6 months(follow up loss patients)
  • Patients with long-term Parkinson's disease, Alzheimer's disease, Guillain-Barre syndrome, myasthenia gravis syndrome, etc.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Department of Rehabilitation Medicine

Bucheon-si, Gyonggido, 14647, South Korea

Location

Department of Rehabilitation Medicine Bucheon St Mary's Hospital, Catholic University of Korea, College of Medicine

Bucheon-si, Kyounggido, South Korea

Location

Related Publications (2)

  • Park HY, Kim Y, Oh HM, Kim TW, Park GY, Im S. Potential Prognostic Impact of Dopamine Receptor D1 (rs4532) Polymorphism in Post-stroke Outcome in the Elderly. Front Neurol. 2021 Jun 30;12:675060. doi: 10.3389/fneur.2021.675060. eCollection 2021.

  • Oh HM, Kim TW, Park HY, Kim Y, Park GY, Im S. Role of rs6265 BDNF polymorphisms and post-stroke dysphagia recovery-A prospective cohort study. Neurogastroenterol Motil. 2021 Jan;33(1):e13953. doi: 10.1111/nmo.13953. Epub 2020 Aug 9.

Biospecimen

Retention: SAMPLES WITH DNA

Blood serum analysis

MeSH Terms

Conditions

StrokeDeglutition Disorders

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesEsophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesPharyngeal DiseasesOtorhinolaryngologic Diseases

Study Officials

  • TaeWoo Kim

    National Traffic Rehabilitation Hospital Korea

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

June 8, 2018

First Posted

July 5, 2018

Study Start

August 4, 2018

Primary Completion

July 30, 2019

Study Completion

August 7, 2019

Last Updated

August 8, 2019

Record last verified: 2019-07

Data Sharing

IPD Sharing
Will not share

Locations